Position in GSK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$54,417,252
-$3,604,929 QoQ
Shares Held
1,038,101
-1.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#40
of 1,033 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. GSK ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in GSK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,417,252 | 1,038,101 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $58,022,181 | 1,051,317 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $45,557,273 | 928,982 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $41,325,352 | 957,492 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $42,266,377 | 1,100,687 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $48,490,853 | 1,251,700 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $34,727,726 | 1,026,840 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $42,387,201 | 1,036,869 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $39,355,352 | 1,022,217 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $47,894,876 | 1,117,212 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $32,917,689 | 888,227 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $31,970,142 | 881,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,488,007 | 883,502 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $35,826,815 | 1,006,937 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $39,362,104 | 1,120,151 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $33,062,601 | 1,123,432 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $47,690,045 | 1,117,014 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $41,411,089 | 969,278 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $33,845,733 | 782,501 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $25,126,740 | 670,469 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $23,490,643 | 601,469 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $16,628,200 | 475,027 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $13,389,907 | 370,979 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||